Swiss National Bank Buys 2300 Shares of Ellie Mae Inc (ELLI)

James Marshall
March 9, 2018

Cognex Corp now has $9.12B valuation. About 243,154 shares traded. Saga Communications, Inc. (NYSEMKT:SGA) has risen 15.97% since March 6, 2017 and is uptrending. It has outperformed by 34.54% the S&P500. Ellie Mae Inc has a 1 year low of $79.71 and a 1 year high of $114.95. Advisor Group Inc. now owns 1,014 shares of the software maker's stock worth $112,000 after purchasing an additional 118 shares in the last quarter. Solutions offered by Ellie include Encompass software, a comprehensive operating system that handles key business and management functions involved in running a mortgage origination business, and serves as a gateway to the Ellie Mae Network. The stock increased 1.23% or $1.14 during the last trading session, reaching $93.81. Ellie Mae, Inc. (NYSE:ELLI) has risen 37.10% since March 8, 2017 and is uptrending. It has outperformed by 20.40% the S&P500.

Ellie Mae (NYSE:ELLI) was downgraded by Zacks Investment Research from a "buy" rating to a "hold" rating in a report issued on Monday, February 12th. Therefore 100% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Friday, July 31 by TH Capital. Shearlink Ltd holds 4.67% in Ellie Mae, Inc. The firm earned "Buy" rating on Wednesday, August 9 by Oppenheimer. Finally, Compass Point assumed coverage on shares of Ellie Mae in a research report on Wednesday, January 3rd. JP Morgan initiated Ellie Mae, Inc. JP Morgan has "Overweight" rating and $82.0 target. (NYSE:ELLI) rating on Friday, September 1. The company was maintained on Thursday, July 23 by RBC Capital Markets. The rating was maintained by Needham on Friday, July 31 with "Buy".

Since October 12, 2017, it had 0 insider purchases, and 16 sales for $11.04 million activity. Shares for $251,333 were sold by SCHREINER GATES CATHLEEN.

In other Ellie Mae news, EVP Brian E. Brown sold 1,695 shares of the stock in a transaction dated Thursday, March 1st. 2,256 shares valued at $206,387 were sold by HIRSCH PETER on Wednesday, February 21. About 1.64 million shares traded or 72.51% up from the average. BLASING KAREN also sold $172,800 worth of Ellie Mae, Inc. LaVay Matthew sold 629 shares worth $56,690. During the same period in the previous year, the business earned $0.46 EPS. William Blair upgraded the shares of ELLI in report on Monday, April 3 to "Outperform" rating. They expect $-0.11 earnings per share, down 466.67% or $0.14 from last year's $0.03 per share.

Investors sentiment decreased to 0.94 in 2017 Q3. Its down 0.08, from 1.02 in 2017Q2.

A number of institutional investors have recently bought and sold shares of the stock. 106 funds opened positions while 696 raised stakes. Swiss National Bank owned about 0.17% of Ellie Mae worth $5,239,000 at the end of the most recent quarter. (NYSE:ELLI). Scout Invests invested in 0.26% or 115,863 shares. Point72 Asia (Hong Kong) owns 224 shares. (NYSE:ELLI) on Thursday, February 15. (NYSE:ELLI) for 177,458 shares. 130,836 were reported by Tiaa Cref Invest Management Limited Liability Co. Pennsylvania-based Sei Investments has invested 0% in Amicus Therapeutics, Inc. (NYSE:ELLI). Kornitzer Cap Mgmt Incorporated Ks reported 0.09% stake. South Dakota Inv Council holds 0.54% or 686,171 shares. The Illinois-based First Tru Advsrs Limited Partnership has invested 0.01% in Ellie Mae, Inc. (NYSE:ELLI). Proshare Advsr Ltd holds 3,479 shares or 0% of its portfolio. (NYSE:ELLI) for 14,000 shares. Tekne Capital Management Limited Liability Company reported 7.14% in Ellie Mae, Inc. (NYSE:ELLI) for 515,365 shares. Guggenheim Cap Limited Liability Corp stated it has 0.01% of its portfolio in Amicus Therapeutics, Inc. It was reported on Mar, 7 by CGNX's profit will be $39.92 million for 57.09 P/E if the $0.23 EPS becomes a reality. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.32 by $0.01. It is down 0.00% since March 7, 2017 and is. Insiders have sold a total of 78,652 shares of company stock worth $7,167,655 over the last 90 days. Shares for $300,002 were sold by HAYDEN DONALD J JR on Tuesday, January 2.

Among 9 analysts covering Amicus Therapeutics (NASDAQ:FOLD), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. (NASDAQ:NTCT) has "Sector Perform" rating given on Thursday, January 19 by RBC Capital Markets. The firm has "Buy" rating by Canaccord Genuity given on Friday, April 1. The stock has "Outperform" rating by CLSA on Tuesday, November 3. The firm has "Buy" rating by Keefe Bruyette & Woods given on Friday, February 23. On Monday, February 13 the stock rating was maintained by Maxim Group with "Hold". The stock has "Sell" rating by RBC Capital Markets on Wednesday, November 29. Stephens reiterated a "hold" rating and set a $92.00 price target on shares of Ellie Mae in a research report on Friday, February 9th. Citigroup maintained it with "Buy" rating and $48 target in Tuesday, July 19 report. The firm has "Buy" rating given on Friday, December 8 by Daiwa Securities. The Pennsylvania-based Godshalk Welsh Cap Mngmt has invested 1.14% in AT&T Inc. Its down 0.19, from 1.25 in 2017Q2. It dived, as 23 investors sold CGNX shares while 135 reduced holdings. 55 funds opened positions while 111 raised stakes. Reilly Financial Advisors Ltd Limited Liability Company holds 47 shares or 0% of its portfolio. 1,688 were reported by Victory Capital Mgmt. Weaver C Barksdale & Assocs Inc stated it has 29 shares or 0% of all its holdings. Efg Asset (Americas) invested 0.13% of its portfolio in Cognex Corporation (NASDAQ:CGNX). Ifc Fl holds 0.05% or 5,911 shares. (NASDAQ:FOLD) or 1.18M shares. It also reduced its holding in Kite Pharma Inc (NASDAQ:KITE) by 309,767 shares in the quarter, leaving it with 496,983 shares, and cut its stake in Biocryst Pharmaceuticals Inc (NASDAQ:BCRX). Citadel Advisors Limited Liability Corporation owns 9,969 shares for 0% of their portfolio. Fmr Ltd Company invested in 1.24 million shares or 0.01% of the stock.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article